Influence of obesity on pharmacokinetics and analgesic effect of ketoprofen administered intravenously to patients after laparoscopic cholecystectomy
- 8 January 2020
- journal article
- research article
- Published by Springer Nature in Pharmacological Reports
- Vol. 72 (3) , 763-768
Abstract
Background Ketoprofen is an analgesic drug commonly applied in the postoperative period, e.g., to patients after laparoscopic cholecystectomy. Many patients who undergo this procedure are obese. As pathophysiological changes are observed in obesity, the efficacy of ketoprofen may be altered in this group of patients. The aim of the study was to compare the pharmacokinetic parameters and analgesic effect of ketoprofen administered to obese and non-obese patients after laparoscopic cholecystectomy. Methods The study was conducted on 41 patients after laparoscopic cholecystectomy, who were divided into two groups: obese (n = 21) and non-obese (n = 20). Ketoprofen was administered intravenously at a dose of 100 mg. Plasma ketoprofen concentrations were measured by means of validated high-performance liquid chromatography with ultraviolet detection. The pharmacokinetic parameters of the drug were calculated using the non-compartmental method. Additionally, pain intensity was assessed during the study using NRS scale. Results The obese patients had significantly lower AUC0−∞ (1.4-fold), AUMC0−t (1.8-fold), AUMC0−∞ (3.2-fold), MRT0−t (1.4-fold), MRT0−∞ (2.3-fold), t0.5 (2.3-fold) and Vz/kg (2.3-fold) and higher kel (2.2-fold) than the non-obese group. Moreover, 4 h and 6 h after the administration of the drug, pain intensity was significantly higher in the obese patients. Conclusions The drug was eliminated faster and the analgesic effect of ketoprofen in the obese patients was decreased as compared with the non-obese subjects. However, pain intensity did not increase to the level, which required additional analgesic treatment. Therefore, it seems that dosage adjustment of intravenous ketoprofen is not necessary in obese patients.Keywords
This publication has 14 references indexed in Scilit:
- Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosingContraception, 2016
- Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured reviewInternational Journal of Antimicrobial Agents, 2016
- Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of AcetaminophenClinical Pharmacokinetics, 2016
- Drug Disposition in Obesity: Toward Evidence-Based DosingAnnual Review of Pharmacology and Toxicology, 2015
- Impact of Obesity on Drug Metabolism and Elimination in Adults and ChildrenClinical Pharmacokinetics, 2012
- Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methodsBritish Journal of Anaesthesia, 2011
- Implications of Obesity for Drug Therapy: Limitations and ChallengesClinical Pharmacology & Therapeutics, 2011
- Effect of Obesity on the Pharmacokinetics of Drugs in HumansClinical Pharmacokinetics, 2010
- The preoperative administration of ketoprofen improves analgesia after laparoscopic cholecystectomy in comparison with propacetamol or postoperative ketoprofenBritish Journal of Anaesthesia, 2004
- Free drug fraction vs. free drug concentration: a matter of frequent confusionJournal of Veterinary Pharmacology and Therapeutics, 2002